Stock Market & Financial Investment News

News Breaks February 21, 2013 08:39 EDT ABMD Abiomed strength should be used as a selling opportunity, says Northland Northland Securities recommends using any strength today as a selling opportunity and said the FDA close-out letter has nothing to do with the Department of Justice/Hippa investigation on off-label marketing. Shares are Underperform rated with a $9 price target. News For ABMD From The Last 14 Days Check below for free stories on ABMD the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 07:42 EDT ABMD Stephens to host a field trip Subscribe for More Information May 13, 2013 09:06 EDT ABMD Abiomed price target raised to $28 from $22 at Stephens Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.